The existence of a bradykinin-like substance in nervous tissue has been reported (1), and the enzymatic inactivation of bradykinin by a neural tissue extract are also confirmed (2, 3).
Male, dd-strain mice, weighing 20 to 25 g were used. Intracerebral injections were made as described by Haley and McCormick (6) . Synthetic bradykinin was obtained from the Institute for Protein Research, Osaka University. The enzyme inactivating bradykinin was purified as described previously (4) . Bradykinin and all compounds and drugs for injection were dissolved in physiologic saline and injected at doses of 0.01 ml per 20 g body weight. Control animals, injected with saline, were always examined in parallel with treated animals. Spontaneous motor activity of animals in a jiggle cage was recorded on smoked paper.
Biological assay
The methods of incubation and determination of kininase activity were as described previously (3) . Fig. 1 shows the effect of the intracerebral dose of bradykinin on spontaneous motor activity in mice. Bradykinin at doses of up to 10 taneous motor activity. Administration of 100 to 500 ,ug/kg of bradykinin immediately resulted in tranquilization.
RESULTS

Effect of bradykinin
Rapid respiration and catatonia were observed. A doses of over 750 i g/ kg, caused first great excitation and then depression. In the phase of excitation, animals ran, jumped, rolled and struggled. The durations of the phases of extreme excitation and depression increased with the dose of bradykinin. After the phase of depression normal activity was resumed.
On tranquilized and recovered. Kininase acti vity was similar in the tranquilized, re covered and normal states but raised in the excited state ( Fig. 3 ). The bradvkinin content in mouse brain in the excited, tranquilized and recovered states could not be estimated accurately, for the kininase in brain was extremely active and the residual bradykinin content was negligible.
Efect of kininase on spontaneous motor actiz'itp
Bradykinin was incubated with partially purified enzyme from rat brain for 0 and 120 hours. This enzyme inactivates brady kinin by removing its phenylalanine' and C-terminal arginine (4). After incubation for 120 hours, bradykinin was completely inactivated by the enzyme. At 0 time and after 120 hours, samples of the mixture of bradykinin and enzyme and of enzyme alone were removed. The enzyme was denatured by heating at 100 C in a water bath for 15 minutes and the resulting supernatant was injected into mice intracerebrally.
The supernatant from the mixture of bradykinin and enzyme, removed at 0 time caused first excitation and then tranquilization. How FiG.3 . Changes in kininase activity in mouse brain after intracerebral injec tion of bradykinin.
After intracerebral injection of 1000 ;og/kg of bradykinin kininase activity in mouse brain was measured in rela tion to behavior (x x : excited state, tranquilized state, : re covered state).
The classification of behavioral stages is described in the text. Saline was administered to cont rol animals (,~] )j). Synthetic brady kinin (5 teg/ml) was incubated with enzyme preparation (supernatant frac tion of brain homogenate after centri fugation at 700 x t' for 10 minutes, enzyme protein 0.3 mg/ml) at 37C. 1'1G.4. (Jhanges in spontaneous motor activity in mouse after intracerebral injeL-uu<< u, bradykinin and,'or enzyme.
Synthetic bradykinin was incubated with a purified enzyme preparation fr;a n rat brain at 25C for 0 and 120 hours. For details see text. ever the supernatant obtained after 120 hours caused no excitation but only depression . The durations of the stage of depression caused by these two supernatants were similar ( Fig. 4 ). Injection of amounts of free arginine or phenylalanine equal to those calculated to be released from bradykinin, caused no change in spontaneous motor activity , and no change was observed on injection of the supernatant of enzyme .
Effect of bradykinin on the sleeping period with hexobarbital Fig. 5 shows that intracerebral injection of 100 beg/kg of bradykinin significantly pro longed the period of sleep with hexobarbital. This effect was also observed after treat ment with inactivated bradykinin.
Effects of various compounds on spontaneous motor activity EDTA and glutathione inhibited the activity of enzyme preparations from mouse and rat brain, whereas NEM and calcium ion increased the activity of partially purified enzyme from rat brain (4) (these effects of NEM and calcium ion were not observed with crude enzyme (3)). Doses of 2 itmoles/kg EDTA and 4 ,umoles/kg glutathione did not produce any change in spontaneous motor activity. A dose of 500 /2g/kg of bradNkinin caused no excitation but tranquilization.
When these compounds were injected together with 500 ,ug/kg of bradykinin, excitation was observed. On the other hand , when 4 /cmoles/ kg calcium chloride or 4 ,tmoles/kg NEM was injected with 750 ,ug/kg of bradykinin, the excitatory state was the same as after 750 ,ug/kg of bradykinin alone (Fig. 6 ).
On injection of EDTA with bradykinin, at the end of the excited phase, spontaneous motor activity was often observed as with EDTA alone, as shown in Fig. 6 .
Effects of aminopyrine and morphine on spontaneous motor activity
As shown in Fig. 7 , administration of aminopyrine or morphine 30 minutes before injection of bradykinin, decreased the subsequent excitation considerably though not completely. Acetylsalicylic acid (50 mg/kg, i.v.) also decreased the excitation slightly . The depressed state was prolonged after injection of morphine and bradykinin . Sodium hexobarbital (H. 70mg/kg) was given intraperitoneally to mice 6 minutes after intracerebral injection of the test preparation.
Horizontal lines indicate the standard error of the mean. The results were evaluated statistically by the student's t test.
Significant difference from the corresponding value for the group receiving saline plus H. or enzyme plus H. (P<0.05).
FIG. 6. Changes in spontaneous motor activity in mouse after intracerebral injection of bradykinin and various compounds.
For details see text.
FIG. 7. Effects of aminopyrine and morphine on spontaneous motor activity in mouse
produced by intracerebral injection of bradykinin. Drugs (aminopyrine and morphine) were injected intravenously 30 minutes before administration of bradykinin.
DISCUSSION
The effect of bradykinin on the central nervous system is not clearly known. Intra ventricular administration of a crude preparation of bradykinin through a Feldberg and Sherwood cannula caused tranquilization in cats (7) . Capek (8) reported that after intraventricular injection of bradykinin, opisthotonus, convulsions , salivation and micturi tion were usually observed in cats, whereas Lewis (9) had only negative results to report with pure bradykinin. Rocha e Silva (10) attributed this discrepancy to the rapid de struction of the peptide when in contact with the lining of the ventricle. In mice, Capek In our present experiments, intracerebral injection of large doses of bradykinin (750 to 1500 ,ug/kg) into mice produced excitation followed by depression, while doses of under 500,ag/kg, caused no excitation. After the stage of depression normal activity was resumed . This shows that the bradykinin administered is quickly inactivated in, or disappears from the brain. The kininase in brain and in blood are very active. The half-life of brady kinin, infused at a rate of 40 ng/minute, is 17 seconds in cat and 80% is destroyed in one passage through the lungs (11) . After intracerebral injection of 1000 ,ug/kg of bradykinin, kininase activity was en hanced in the excited state, but similar in the tranquilized, recovered and normal states . A dose 1000 ug/kg of bradykinin which had been completely inactivated by the enzyme , caused only the depressed state, the duration of which was almost the same as that after injection of untreated bradykinin. These results suggest that the excited state is caused by bradykinin itself.
Inactivated bradykinin also prolonged the sleeping period with hexobarbital . The enzyme used in this study inactivates bradykinin by removing phenylalanine8 and C terminal arginine (4) . The depressed state might be induced by the products split from bradykinin, phenylalaninee and arginine9, but at the concentrations calculated to be from bradykinin neither had an effect on the spontaneous motor activity. When 500 ,ug/kg of bradykinin, which alone caused no excitation, was administered with kininase inhibitor (EDTA, glutathione) in vitro, it caused excitation. Thus, kininase in the central nervous system may be very important in the mechanism of excitation caused by bradykinin . Often, on simultaneous injection of EDTA and bradykinin , spontaneous motor activity rather than depression was noted, as shown in Fig. 6 . This might be due to the excitatory effect of EDTA itself, for a large dose of EDTA (above 2 ,amoles/kg) produces excitation (12) . On the other hand, calcium ion or NEM, which increase enzyme activity in vitro, did not reduce the effect of bradykinin in vivo. It is uncertain whether these compounds act the same way in vivo as in vitro, for purified enzyme has not yet been obtained from mouse brain.
It has been reported that aminopyrine , acetylsalicylic acid and morphine block the action of bradykinin in vivo and in vitro (13) . In the present experiments, aminopyrine, acetylsalicylic acid and morphine reduced the excitation caused by bradykinin . Kaneko et al. (14) also reported that intraventricular administration of synthetic bradykinin to rabbits caused extreme excitation, animals jumping and squeaking, and that this excita tion was blocked by acetylsalicylic acid. Our results are very interesting for they indicate that acetylsalicylic acid and aminopyrine tend to potentiate the enzymatic inactivation of bradykinin (4).
SUMMARY
Bradykinin was injected intracerebrally into mice. With large doses (over 750 pg/kg), animals showed excitation followed by depression while with under 500 /-Ig/kg no excitation was observed.
Kininase activity was increased in the excited state and bradykinin prolonged the sleeping period with hexobarbital. The same effect was observed with inactivated brady kinin. From these results, it seems that the excited state may be induced by intact brady kinin and products split from bradykinin may cause the depressed state. Simultaneous injection of EDTA or glutathione with a dose of bradykinin causing no excitation, produced excitation. These compounds inhibit kininase activity in vivo as well as in vitro.
